Observational studyBMC cancer2021

Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients.

You-Yi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.